Skip to Content

ResMed Inc RMD Stock Quote

| Rating as of


Last close prices updated as of Jan 27, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 224.59
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Investment Style Mid Growth
  • Day Range 221.58  –  235.53
  • Year Range 189.40  –  262.38
  • Market Cap 32.8988 Bil
  • Volume / Avg 1.2 Mil /  579,459.4
  • Price / Sales 8.79
  • Price / Book 8.83
  • Forward Div Yield 0.77%
  • Trailing Div Yield 0.77%

Morningstar‘s Stock Analysis RMD

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


ResMed Faces Near-Term Supply Constraints, but Long-Term Outlook Is Sound

Shane Ponraj Equity Analyst

Business Strategy and Outlook

| Shane Ponraj |

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud-connected devices, physicians can monitor patient compliance and encourage continued use. Higher adherence supports both reimbursement rates from payers and the resupply of masks and accessories. ResMed also plays a key role in producing clinical data that demonstrates treatment can minimise related risks such as hypertension, stroke, heart attack and Alzheimer’s disease. Through its own testing devices and education, ResMed seeks more widespread diagnosis and treatment of OSA.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics RMD

Company Profile RMD

Business Description

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

9001 Spectrum Center Boulevard
San Diego, CA, 92123
Industry Medical Instruments & Supplies
Employees 8,160

Related Articles RMD

FAQs for ResMed Inc Stock

Yes. RMD has a forward dividend yield of 0.77%. See RMD’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

RMD’s market cap is 32.90 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

RMD’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

RMD’s price/sales is 8.79.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

RMD’s price/forward earnings is 37.59.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

RMD’s price/book is 8.83.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See RMD’s valuation ratios compared to the Market Index.

RMD’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare RMD’s historical performance against its industry peers and the overall market.